{"version":"1.0","provider_name":"Pharma &amp; Biotech Patent Litigation USA &amp; Canada","provider_url":"https:\/\/www.americanconference.com\/pharma-biotech-patent-litigation-usa","title":"Earn CLE Credits | Pharma &amp; Biotech Patent Litigation USA &amp; Canada","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"0yZgaJXE6v\"><a href=\"https:\/\/www.americanconference.com\/pharma-biotech-patent-litigation-usa\/earn-cle-credits\/\">Earn CLE Credits<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.americanconference.com\/pharma-biotech-patent-litigation-usa\/earn-cle-credits\/embed\/#?secret=0yZgaJXE6v\" width=\"600\" height=\"338\" title=\"&#8220;Earn CLE Credits&#8221; &#8212; Pharma &amp; Biotech Patent Litigation USA &amp; Canada\" data-secret=\"0yZgaJXE6v\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.americanconference.com\/pharma-biotech-patent-litigation-usa\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation. ACI certifies this activity has been approved for CLE credit by the New York State Continuing Legal Education Board. ACI certifies this activity has been approved for&hellip;","thumbnail_url":"https:\/\/www.americanconference.com\/pharma-biotech-patent-litigation-usa\/wp-content\/uploads\/sites\/2222\/2026\/04\/796L27_linkedin_general_1200x1200.jpg","thumbnail_width":1200,"thumbnail_height":1200}